Yew Bio Pharm Cash Flow - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.33 $0 (0%) YEWB stock closing price Feb 24, 2017 (Closing)

The Yew Bio Pharm cash flow statement helps investors understand how well the company is managing its cash flows. While its important to look at the Yew Bio Pharm debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Yew Bio Pharm revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Yew Bio Pharm stock analysis shows positive net income cash flow of $3.43M for 2016-Q3. This statement is important because profits alone cannot pay employees, or bills. Cash is required.   YEWB decrease in investments stood at a negative value of $-0.01M for the latest 2016-Q3. View details of Yew Bio Pharm cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Yew Bio Pharm Net Income Cash Flow
3.43M2.35M1.05M5.28M3.89M2.96M0.95M4.28M3.68M2.79M
Depreciation Depletion Amortization Cash-Flow8.87M8.87M5.02M7.74M1.22M0.33M0.16M0.68M0.51M0.34M
Net Increase (Decrease) in Assets Liabilities-12.19M-11.16M-6.57M-15.43M-7.09M-5.41M-1.78M-1.35M-1.03M-0.28M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.24M0.16M0.08M1.03M0.77M0.55M0.3M0.5M0.32M-
Yew Bio Pharm Net Cash from (used by) Operating Activities
0.36M0.22M-0.41M-1.37M-1.2M-1.57M-0.35M4.11M3.49M2.85M
Increase (Decrease) in Prop Plant And Equipment-0.01M---0.02M-1.37M-0.59M---4.5M-3.75M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----2.33M----2.44M--
Yew Bio Pharm Net Cash from (used by) Invesment Activities
-0.01M---2.36M-1.37M-0.59M--2.44M-4.5M-3.75M
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings---3.21M1.64M1.64M----
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.04M-0.03M-0.02M0.74M0.65M0.65M--2.33M-0.02M-0.02M
Yew Bio Pharm Net Cash from (used by) Financing Activities
-0.04M-0.03M-0.02M3.96M2.29M2.29M--2.33M-0.02M-0.02M
Effect of Exchange Rate Changes on Cash-0.02M-0.01M--0.03M-0.03M---0.01M-0.01M-0.01M
Yew Bio Pharm Net Change in Cash & Cash Equivalents
0.28M0.16M-0.44M0.19M-0.31M0.12M-0.35M-0.67M-1.03M-0.92M
Cash & Equivalents at Beginning of Year0.48M1.15M0.38M0.73M1.85M-----
Cash & Equivalents at Year End0.96M0.84M0.23M0.68M0.17M0.61M0.12M0.48M0.12M0.23M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

Yew Bio Pharm stock price history provides insight into historical stock price fluctuations, and Yew Bio Pharm stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:
  • Net Change in Cash and Cash Equivalents: Yew Bio Pharm cash grew QoQ to $3.43M, meaning the company is able to meet its expenditure and grow cash which will also eventually reflect in the Yew Bio Pharm stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $0.36M for YEWB.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-0.01M for YEWB stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-0.04M for Yew Bio Pharm.
.

Key Financial Ratios For Yew Bio Pharm Cash Flow

FCF margin
0.01